Healthcare Innovations, 4
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.27 |
AERI | Aerie Pharmaceuticals, Inc. | 3.32 |
AGIO | Agios Pharmaceuticals, Inc. | 3.40 |
ALNY | Alnylam Pharmaceuticals, Inc. | 3.56 |
ALXN | Alexion Pharmaceuticals, Inc. | 3.38 |
ARRY | Array BioPharma Inc. | 3.31 |
BGNE | BeiGene, Ltd. | 3.54 |
BLUE | bluebird bio, Inc. | 3.55 |
CLVS | Clovis Oncology, Inc. | 3.44 |
DBVT | DBV Technologies S.A. | 3.33 |
DERM | Dermira, Inc. | 3.49 |
ENDP | Endo International plc | 3.21 |
FGEN | FibroGen, Inc. | 3.57 |
GBT | Global Blood Therapeutics, Inc. | 3.20 |
GWPH | GW Pharmaceuticals plc | 3.35 |
HALO | Halozyme Therapeutics, Inc. | 4.06 |
HZNP | Horizon Pharma plc | 3.01 |
ICPT | Intercept Pharmaceuticals, Inc. | 2.48 |
IRWD | Ironwood Pharmaceuticals, Inc. | 3.45 |
JAZZ | Jazz Pharmaceuticals plc | 3.36 |
LGND | Ligand Pharmaceuticals Incorporated | 3.32 |
LOXO | Loxo Oncology, Inc. | 3.77 |
MDCO | The Medicines Company | 3.02 |
NBIX | Neurocrine Biosciences, Inc. | 3.29 |
NKTR | Nektar Therapeutics | 3.30 |
PBYI | Puma Biotechnology, Inc. | 3.25 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.39 |
SAGE | Sage Therapeutics, Inc. | 2.48 |
SUPN | Supernus Pharmaceuticals, Inc. | 3.38 |
XLRN | Acceleron Pharma Inc. | 3.52 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.27 |
XLRN | Acceleron Pharma Inc. | 3.52 |
AERI | Aerie Pharmaceuticals, Inc. | 3.32 |
AGIO | Agios Pharmaceuticals, Inc. | 3.40 |
ALXN | Alexion Pharmaceuticals, Inc. | 3.38 |
ALNY | Alnylam Pharmaceuticals, Inc. | 3.56 |
ARRY | Array BioPharma Inc. | 3.31 |
BGNE | BeiGene, Ltd. | 3.54 |
BLUE | bluebird bio, Inc. | 3.55 |
CLVS | Clovis Oncology, Inc. | 3.44 |
DBVT | DBV Technologies S.A. | 3.33 |
DERM | Dermira, Inc. | 3.49 |
ENDP | Endo International plc | 3.21 |
FGEN | FibroGen, Inc. | 3.57 |
GBT | Global Blood Therapeutics, Inc. | 3.20 |
GWPH | GW Pharmaceuticals plc | 3.35 |
HALO | Halozyme Therapeutics, Inc. | 4.06 |
HZNP | Horizon Pharma plc | 3.01 |
ICPT | Intercept Pharmaceuticals, Inc. | 2.48 |
IRWD | Ironwood Pharmaceuticals, Inc. | 3.45 |
JAZZ | Jazz Pharmaceuticals plc | 3.36 |
LGND | Ligand Pharmaceuticals Incorporated | 3.32 |
LOXO | Loxo Oncology, Inc. | 3.77 |
MDCO | The Medicines Company | 3.02 |
NKTR | Nektar Therapeutics | 3.30 |
NBIX | Neurocrine Biosciences, Inc. | 3.29 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.39 |
PBYI | Puma Biotechnology, Inc. | 3.25 |
SAGE | Sage Therapeutics, Inc. | 2.48 |
SUPN | Supernus Pharmaceuticals, Inc. | 3.38 |
Summary
Description
-
Trust Name Healthcare Innovations, 4
-
Trust Symbol SMHCDX
Deposit Data
-
Deposit Date 11/01/2017
-
Termination Date 20191101
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.00
CUSIP
-
Cash Cusip 83188M101
-
Reinvest Cusip 83188M119
-
Fee Cash Cusip 83188M127
-
Fee Invest Cusip 83188M135
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.